// App-Quantinova.ai

2328 : Spontaneous Heparin-Induced Thrombocytopenia Syndrome: Two New Cases and a Proposal For Defining This Disorder

Researchers

Presenter

  • Theodore E. Warkentin

Principal Investigators

  • Paul Andrew Basciano

  • Richard A. Bernstein

Medical Centers

  • Northwestern University, Chicago, IL

  • Division of Hematology & Medical Oncology, Weill Cornell Medical College, New York, NY

  • Department of Medicine, McMaster University, Hamilton, ON, Canada

Locations

  • United States

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Deep vein thrombosis

  • Thrombocytopenia

  • Venous thrombosis

  • Stroke

Biomarkers

  • N/A

Drug/Treatment

  • Fondaparinux sodium

  • Argatroban

  • Aspirin

  • Albyl-E

  • Heparin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved